Ikue Hata

Ikue Hata

Auto-generated profile, based on publicly available information

Ikue Hata

University of Fukui

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


1 December 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
GTGo Tajima
Go Tajima
KHKeiichi Hara
Keiichi Hara
MTMiyuki Tsumura
Miyuki Tsumura
RKReiko Kagawa
Reiko Kagawa
SOSatoshi Okada
Satoshi Okada
MKMasao Kobayashi
Masao Kobayashi

19 July 2005 in Journal of Chromatography B
Verified
Journal Article
Closed access
GTGo Tajima
Go Tajima
NSNobuo Sakura
Nobuo Sakura
HYHiroko Yofune
Hiroko Yofune
YNYutaka Nishimura
Yutaka Nishimura
HOHiroaki Ono
Hiroaki Ono
MKMasao Kobayashi
Masao Kobayashi

1 January 2015 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
SKSayaka Kato
Sayaka Kato
YNYoko Nakajima
Yoko Nakajima
RARisa Awaya
Risa Awaya
IHIkue Hata
Ikue Hata
YSYosuke Shigematsu
Yosuke Shigematsu
TITetsuya Ito
Tetsuya Ito
Fructose-1,6-bisphosphatase (FBPase), an enzyme involved in gluconeogenesis, catalyzes the hydrolysis of fructose-1,6-bisphosphate to fructose-6-phosphate and inorganic phosphate. FBPase deficiency is an autosomal recessive inherited disorder, characterized by episodic attacks of hypoglycemia, ketosis, and lactic acidosis during fasting. In general, urinary organic acid analysis using gas chromatography-mass spectrometry (GC/MS) is very useful for the diagnosis of FBPase deficiency, because the appearance of glycerol or glycerol-3-phosphate in the urine is characteristic of this disease. Here, we report a case of FBPase deficiency in a girl with a history of several severe lactic acidosis events, both as a neonate and after the age of 12 months. The patient was identified as a compound heterozygote with two mutations in the FBPase 1 gene: c.841G>A (p.Glu281Lys) and c.960_961insG (p.Ser321fs). The c.841G>A is a newly identified pathogenic mutation. An abnormal level of glycerol-3-phosphate was not detected in the conventional urinary organic acid analysis using GC/MS after solvent extraction. This method, which is a widely used diagnostic standard, could not detect increased levels of glycerol or glycerol-3-phosphate in the patient's urine, which was sampled during the episode. However, glycerol and glycerol-3-phosphate were detected in the same sample, when it was analyzed using GC/MS with the urease pretreatment non-extraction method. Patients with FBPase deficiency have good glycemic control after correct treatment. Therefore, accurate and early diagnosis is essential for a good prognosis. Accordingly, when a patient presents with hypoglycemia and lactic acidosis, it is important to select the appropriate method of urinalysis for organic acids by GC/MS.

25 March 2022 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
YOYoshimitsu Osawa
Yoshimitsu Osawa
HKHironori Kobayashi
Hironori Kobayashi
GTGo Tajima
Go Tajima
KHKeiichi Hara
Keiichi Hara
KYKenji Yamada
Kenji Yamada
TTTakeshi Taketani
Takeshi Taketani